SQZ Biotechnologies Company (SQZB)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 107.18 Million USD | -52.6% |
| 2021 | 226.15 Million USD | -2.16% |
| 2020 | 231.14 Million USD | 51.72% |
| 2019 | 152.35 Million USD | 31.85% |
| 2018 | 115.54 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q2 | 54.14 Million USD | -25.98% |
| 2023 Q1 | 73.15 Million USD | -31.75% |
| 2023 Q3 | 29.78 Million USD | -44.99% |
| 2022 Q1 | 200.79 Million USD | -11.21% |
| 2022 Q3 | 154.85 Million USD | -14.12% |
| 2022 Q4 | 107.18 Million USD | -30.78% |
| 2022 Q2 | 180.31 Million USD | -10.2% |
| 2022 FY | 107.18 Million USD | -52.6% |
| 2021 Q3 | 244.07 Million USD | 0.0% |
| 2021 FY | 226.15 Million USD | -2.16% |
| 2021 Q4 | 226.15 Million USD | -7.34% |
| 2020 FY | 231.14 Million USD | 51.72% |
| 2019 FY | 152.35 Million USD | 31.85% |
| 2018 FY | 115.54 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 2310.00 USD | -4640029.87% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -5373.782% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -915.605% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -19313.714% |
| Rebus Holdings, Inc. | 5000.00 USD | -2143640.0% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 17.682% |
| Qrons Inc. | 420.00 USD | -25520614.286% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -13808.757% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -283.578% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -22204.742% |
| Skye Bioscience, Inc. | 11.94 Million USD | -797.683% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | -175.921% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -1384.633% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -140281.643% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -7384.958% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -148019.947% |
| Mesoblast Limited | 667.9 Million USD | 83.952% |
| Marizyme, Inc. | 22.01 Million USD | -386.88% |
| Genus plc | 1.02 Billion USD | 89.582% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -7790.953% |
| Pharming Group N.V. | 462.85 Million USD | 76.842% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -3135.334% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -21378.682% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -16995.215% |
| ContraFect Corporation | 20.67 Million USD | -418.337% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -27358.078% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -27946.429% |
| IMV Inc. | 31.33 Million USD | -242.081% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -2485.297% |
| MultiCell Technologies, Inc. | 126.22 USD | -84920673.253% |
| ONE Bio Corp. | 70.08 Million USD | -52.937% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -11306.646% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 16.592% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -24728.243% |
| Q BioMed Inc. | 3.51 Million USD | -2948.968% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -204.69% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -40924.277% |
| Biomind Labs Inc. | 73.81 Thousand USD | -145102.455% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 75.984% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -7298.11% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -257.112% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -3802.911% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -15491.154% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -4017.516% |
| GB Sciences, Inc. | 103.44 Thousand USD | -103520.386% |
| Alpha Cognition Inc. | 2.45 Million USD | -4271.108% |
| HST Global, Inc. | 1526.00 USD | -7023949.803% |
| CSL Limited | 38.02 Billion USD | 99.718% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -10749.249% |
| Halberd Corporation | 10.13 Thousand USD | -1057910.068% |
| Enzolytics Inc. | 361.7 Million USD | 70.366% |
| Agentix Corp. | 261.39 Thousand USD | -40906.228% |
| Resverlogix Corp. | 8.11 Million USD | -1220.85% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -5607.873% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 97.64% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | -124.701% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -16656.976% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -470410.513% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -1097.733% |
| AVAX Technologies, Inc. | 7.37 Million USD | -1352.958% |
| Zenith Capital Corp. | 7410.00 USD | -1446418.219% |
| Genscript Biotech Corporation | 3.38 Billion USD | 96.835% |
| Ember Therapeutics, Inc. | 184.00 USD | -58253704.348% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -33207.956% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -40910.621% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -11450.809% |
| Kadimastem Ltd | 2.3 Million USD | -4552.052% |
| Helix BioMedix, Inc. | 3.02 Million USD | -3443.271% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | -103.387% |
| BioStem Technologies, Inc. | 14.56 Million USD | -636.16% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -187637.766% |
| LadRx Corporation | 2.3 Million USD | -4544.388% |
| Cell Source, Inc. | 195.17 Thousand USD | -54819.532% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -30211.608% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -30211.608% |
| NovAccess Global Inc. | 62.24 Thousand USD | -172093.484% |
| Affymax, Inc. | 7.44 Million USD | -1340.105% |
| Itoco Inc. | 1.4 Million USD | -7555.821% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -111953.483% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -101019.811% |
| Mobile Lads Corp. | 52.00 USD | -206128746.154% |
| CytoDyn Inc. | 11.13 Million USD | -862.527% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -74870.624% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -599379.866% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -27706.761% |
| SYBLEU INC | 330.46 Thousand USD | -32334.91% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -26080.078% |
| International Stem Cell Corporation | 5.39 Million USD | -1888.627% |
| Bioxytran, Inc. | 137.63 Thousand USD | -77776.023% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -614.493% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -546.523% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -135579.747% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -12296.19% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -1325.928% |
| Neutra Corp. | 2851.00 USD | -3759528.201% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -230.763% |
| PureTech Health plc | 693.97 Million USD | 84.555% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -1228.036% |
| IXICO plc | 15.84 Million USD | -576.519% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -1194.216% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -3.739% |
| CSL Limited | 38.02 Billion USD | 99.718% |
| Cellectis S.A. | 333.99 Million USD | 67.908% |